Drug Discovery World

DECEMBER 7, 2022

The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment. Change has to come from the top down for life sciences to build a more inclusive culture,” added Ciobanu. “By What was holding women back? .

Pharma Companies 52

Pharma Companies Life Science Regulation Scientist 52

pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 106

Pharma Companies Life Science Development Production 106

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Sales 147

Drug Discovery World

DECEMBER 14, 2023

With leading academic institutions and significant recent investment, Glasgow is shaping up to be an important centre for drug discovery and development in the UK. A centre of excellence for cancer research The announcement of the new Health Innovation Hub follows other examples of significant investment in Glasgow life sciences.

Drugs 75

Drugs Life Science Research Scientist 75

XTalks

MAY 20, 2021

The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Pharma Companies Development Drugs 52

Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine. We have 3,000 companies in the life sciences sector.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Pharmaceutical Technology

JANUARY 31, 2023

The US omnibus bill passed in late December 2022 will give the agency greater powers to regulate accelerated approval drugs, while the Inflation Reduction Act’s lowering of drug prices will create an uncertain environment for drug developers, he said. That leaves three years for pharma companies to prepare.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form.

Life Science 69

Life Science Drugs Branding Medicine 69

pharmaphorum

MAY 12, 2022

German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to life sciences companies. ” The post Boehringer sells drug safety software to ArisGlobal appeared first on.

Drugs 52

Drugs Life Science Pharma Companies Development 52

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . The post Digitalising drug discovery appeared first on.

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Then there is the cost of generic drugs.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

DECEMBER 6, 2023

The industry has responded that these sales rebate levels have damaged the UK’s international standing with global life science companies and are likely to continue to negatively impact UK life sciences and NHS patients’ access to medicines. in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

XTalks

APRIL 16, 2024

Lady Gaga’s continuing partnership with Pfizer has yielded another video ad for the company’s migraine drug Nurtec ODT (Rimegepant). Watch the ad here: Lady Gaga’s Journey, The Next Chapter The ad opens with Gaga saying “Nothing dims my light like a migraine” and goes on to reveal how she found relief with migraine drug Nurtec ODT.

Drugs 52

Drugs Pharma Companies Doctors Doctor 52

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

Drug Discovery World

OCTOBER 6, 2022

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? The European drug discovery sector is buoyant. With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. Valued at $14.8

Development 52

Development Drugs Life Science Marketing 52

XTalks

AUGUST 21, 2023

The US Food and Drug Administration (FDA) has approved Ipsen’s groundbreaking Sohonos (palovarotene) capsules for the treatment of fibrodysplasia ossificans progressive (FOP), an ultra-rare bone disease. The median life expectancy of patients with FOP is 56, making it a severe and often misdiagnosed disease.

Drugs 98

Drugs FDA Approval Genetics Clinical Trials 98

Pharmaceutical Technology

JULY 26, 2022

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. The business combination has obtained unanimous approvals from the board of directors of NewAmsterdam Pharma and FLAC.

Life Science 147

Life Science Trials Pharma Companies Production 147

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Interestingly, the company’s blockbuster diabetes drug, Mounjaro (tirzepatide), is not available through the new digital service.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 102

Life Science Engineer Scientist Pharma Companies 102

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data.

Drugs 52

Drugs Marketing Life Science Regulation 52

Drug Channels

OCTOBER 15, 2021

Jayne discusses changes in the life science and specialty pharmacy industries since the COVID-19 pandemic began. She highlights three key trends that pharma companies, plan sponsors, and others will consider as we head to the upcoming Asembia Specialty Pharmacy Summit (October 26 to 29 in Las Vegas).

Pharmacy 58

Pharmacy Life Science Pharma Companies Drugs 58

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

OCTOBER 12, 2023

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform. However, in life science, labeled data are often in short supply. Traditional AI methods require vast amounts of labeled data to make accurate predictions.

Development 52

Development Protein Life Science Pharma Companies 52

XTalks

OCTOBER 4, 2023

How is the shift toward value-based healthcare affecting drug pricing and reimbursement? There is a world where the way we have done things up until now from a pricing, health economics and access perspective is well-suited to meet the needs of drug reimbursement stakeholders, and where we would probably keep doing it.

Marketing 105

Marketing Development Drugs Gene Therapy 105

Drug Discovery World

OCTOBER 18, 2022

The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences. To prepare for this change, the Alliance believes that companies working together on assessing the impact of trials is a key starting point.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. The combination of health and data, he passionately believes, will transform life sciences. And he has a unique view of how data and health combine.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

MARCH 2, 2022

Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 99

Life Science Clinical Trials Clinical Trials Trials 99

Drug Discovery World

MAY 22, 2023

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning are among the key areas of investment for pharma, according to a new report. Clarivate’s ‘Biopharma Dealmaking in 2023’ report examines how pharma companies are replenishing their pipelines as many face a steep patent cliff.

RNA 52

RNA Pharma Companies Antibody Life Science 52

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Automated systems have become a prominent feature throughout drug discovery, helping scientists save time and assisting in reproducible experiments for more verifiable results.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52